Logo image of MSBI

MIDLAND STATES BANCORP INC (MSBI) Stock Fundamental Analysis

NASDAQ:MSBI - Nasdaq - US5977421057 - Common Stock - Currency: USD

18.73  +0.07 (+0.38%)

Fundamental Rating

3

Overall MSBI gets a fundamental rating of 3 out of 10. We evaluated MSBI against 394 industry peers in the Banks industry. MSBI has a bad profitability rating. Also its financial health evaluation is rather negative. MSBI has a valuation in line with the averages, but it does not seem to be growing. Finally MSBI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MSBI has reported negative net income.
In the past year MSBI had a positive cash flow from operations.
Of the past 5 years MSBI 4 years were profitable.
Of the past 5 years MSBI 4 years had a positive operating cash flow.
MSBI Yearly Net Income VS EBIT VS OCF VS FCFMSBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

1.2 Ratios

MSBI has a worse Return On Assets (0.56%) than 72.34% of its industry peers.
MSBI has a worse Return On Equity (5.32%) than 75.38% of its industry peers.
Industry RankSector Rank
ROA 0.56%
ROE 5.32%
ROIC N/A
ROA(3y)1.04%
ROA(5y)0.87%
ROE(3y)10.97%
ROE(5y)8.97%
ROIC(3y)N/A
ROIC(5y)N/A
MSBI Yearly ROA, ROE, ROICMSBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

The Profit Margin of MSBI (14.69%) is worse than 76.14% of its industry peers.
In the last couple of years the Profit Margin of MSBI has grown nicely.
MSBI does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 14.69%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y36.3%
PM growth 5Y6.98%
GM growth 3YN/A
GM growth 5YN/A
MSBI Yearly Profit, Operating, Gross MarginsMSBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

3

2. Health

2.1 Basic Checks

MSBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for MSBI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MSBI Yearly Shares OutstandingMSBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
MSBI Yearly Total Debt VS Total AssetsMSBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

The Debt to FCF ratio of MSBI is 0.92, which is an excellent value as it means it would take MSBI, only 0.92 years of fcf income to pay off all of its debts.
MSBI has a better Debt to FCF ratio (0.92) than 75.13% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that MSBI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, MSBI is in line with its industry, outperforming 46.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.92
Altman-Z N/A
ROIC/WACCN/A
WACC15.65%
MSBI Yearly LT Debt VS Equity VS FCFMSBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MSBI Yearly Current Assets VS Current LiabilitesMSBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2

3. Growth

3.1 Past

The earnings per share for MSBI have decreased strongly by -124.91% in the last year.
EPS 1Y (TTM)-124.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.76%

3.2 Future

Based on estimates for the next years, MSBI will show a very strong growth in Earnings Per Share. The EPS will grow by 142.25% on average per year.
Based on estimates for the next years, MSBI will show a small growth in Revenue. The Revenue will grow by 1.63% on average per year.
EPS Next Y465.38%
EPS Next 2Y142.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.74%
Revenue Next 2Y1.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

MSBI Yearly Revenue VS EstimatesMSBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
MSBI Yearly EPS VS EstimatesMSBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MSBI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 6.92, the valuation of MSBI can be described as very cheap.
Based on the Price/Forward Earnings ratio, MSBI is valued cheaply inside the industry as 91.12% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MSBI to the average of the S&P500 Index (35.19), we can say MSBI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.92
MSBI Price Earnings VS Forward Price EarningsMSBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MSBI is valued cheaper than 97.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.52
EV/EBITDA N/A
MSBI Per share dataMSBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MSBI's earnings are expected to grow with 142.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y142.25%
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

MSBI has a Yearly Dividend Yield of 6.56%, which is a nice return.
MSBI's Dividend Yield is rather good when compared to the industry average which is at 3.31. MSBI pays more dividend than 94.16% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, MSBI pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.56%

5.2 History

The dividend of MSBI is nicely growing with an annual growth rate of 11.38%!
MSBI has been paying a dividend for at least 10 years, so it has a reliable track record.
MSBI has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)11.38%
Div Incr Years8
Div Non Decr Years8
MSBI Yearly Dividends per shareMSBI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

82.20% of the earnings are spent on dividend by MSBI. This is not a sustainable payout ratio.
The dividend of MSBI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP82.2%
EPS Next 2Y142.25%
EPS Next 3YN/A
MSBI Yearly Income VS Free CF VS DividendMSBI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
MSBI Dividend Payout.MSBI Dividend Payout, showing the Payout Ratio.MSBI Dividend Payout.PayoutRetained Earnings

MIDLAND STATES BANCORP INC

NASDAQ:MSBI (7/14/2025, 12:23:57 PM)

18.73

+0.07 (+0.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-24 2025-07-24/amc
Inst Owners66%
Inst Owner Change0%
Ins Owners3.26%
Ins Owner Change1.13%
Market Cap403.07M
Analysts48.89
Price Target19.89 (6.19%)
Short Float %2.13%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 6.56%
Yearly Dividend1.62
Dividend Growth(5Y)11.38%
DP82.2%
Div Incr Years8
Div Non Decr Years8
Ex-Date05-16 2025-05-16 (0.31)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.38%
Min EPS beat(2)-71.98%
Max EPS beat(2)13.22%
EPS beat(4)2
Avg EPS beat(4)-20.87%
Min EPS beat(4)-71.98%
Max EPS beat(4)13.22%
EPS beat(8)5
Avg EPS beat(8)-10.2%
EPS beat(12)9
Avg EPS beat(12)-4.91%
EPS beat(16)10
Avg EPS beat(16)-7.22%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-4.72%
Max Revenue beat(2)-0.32%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-4.72%
Max Revenue beat(4)2.06%
Revenue beat(8)3
Avg Revenue beat(8)1.19%
Revenue beat(12)4
Avg Revenue beat(12)0.82%
Revenue beat(16)4
Avg Revenue beat(16)-0.52%
PT rev (1m)0%
PT rev (3m)-10.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.92
P/S 1.36
P/FCF 2.52
P/OCF 2.43
P/B 0.49
P/tB 0.65
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)2.71
Fwd EY14.46%
FCF(TTM)7.42
FCFY39.63%
OCF(TTM)7.69
OCFY41.07%
SpS13.76
BVpS38.02
TBVpS29.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 5.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.69%
GM N/A
FCFM 53.96%
ROA(3y)1.04%
ROA(5y)0.87%
ROE(3y)10.97%
ROE(5y)8.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y36.3%
PM growth 5Y6.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.92
Debt/EBITDA N/A
Cap/Depr 49.76%
Cap/Sales 1.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 367.25%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC15.65%
ROIC/WACCN/A
Cap/Depr(3y)41.75%
Cap/Depr(5y)34.79%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.6%
Profit Quality(3y)293.47%
Profit Quality(5y)814.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-124.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.55%
EPS Next Y465.38%
EPS Next 2Y142.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.76%
Revenue Next Year1.74%
Revenue Next 2Y1.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.46%
FCF growth 3Y-33.52%
FCF growth 5Y10.17%
OCF growth 1Y-30.85%
OCF growth 3Y-32.33%
OCF growth 5Y9.75%